Preemptive Analgesia for Primary Dysmenorrhoea

• Status: Completed
• Trial end date: 2017-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Preemptive analgesia before the release of pain mediators

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hanan Nabil
• Treatments: Mefenamic Acid

Criteria

Inclusion Criteria:

• nulliparous ladies

• with regular menstrual cycle pattern

• those experienced history of dysmenorrhea (primary or spasmodic)

• patients able to sallow tables

Exclusion Criteria:

• irregular cycles

• any associated local causes( pelvic infection, endometriosis, fibroid or others)

• patients with familial Mediterranean fever or other intermenstrual attacks of abdominal pain

• gastric or duodenal ulcers or gastritis

• other contraindications to non steroidal anti-inflammatory drugs

• patients with severe diminution of vision or color discrimination

• patients with any depressive or mood disorders

• patients receiving any hormonal treatment